APA (7th ed.) Citation

LD, Z., RM, S., MM, N., AB, P., NB, H., AO, O., . . . AG, R. (2025). Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025. MMWR. Morbidity and mortality weekly report, 74(37), 580. https://doi.org/10.15585/mmwr.mm7437a1

Chicago Style (17th ed.) Citation

LD, Zambrano, et al. "Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025." MMWR. Morbidity and Mortality Weekly Report 74, no. 37 (2025): 580. https://doi.org/10.15585/mmwr.mm7437a1.

MLA (9th ed.) Citation

LD, Zambrano, et al. "Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025." MMWR. Morbidity and Mortality Weekly Report, vol. 74, no. 37, 2025, p. 580, https://doi.org/10.15585/mmwr.mm7437a1.